TrialPharmaceutical research2025

Single- and Multiple-dose Pharmacokinetics, Excretion, Metabolism, and Safety of the Antivirulence Agent Fluorothiazinone in Healthy Adults.

Mark V Savitskii et al.PubMed ↗Publisher ↗

No numbers read from the abstract.